KIF23 and liver cancer: In mice, hydrodynamic tail vein injection of pre-miR-107 or anti-Kif23 shRNA effectively inhibited c-Myc-NRAS-induced aggressive liver cancer, highlighting miR-107/KIF23 as a potential therapeutic target [33].